Invention Grant
US09572865B2 Activin-actriia antagonists and uses for treating multiple myeloma
有权
活化素活性拮抗剂和用于治疗多发性骨髓瘤的用途
- Patent Title: Activin-actriia antagonists and uses for treating multiple myeloma
- Patent Title (中): 活化素活性拮抗剂和用于治疗多发性骨髓瘤的用途
-
Application No.: US13460342Application Date: 2012-04-30
-
Publication No.: US09572865B2Publication Date: 2017-02-21
- Inventor: John Knopf , Jasbir Seehra , Ravindra Kumar
- Applicant: John Knopf , Jasbir Seehra , Ravindra Kumar
- Applicant Address: US MA Cambridge
- Assignee: Acceleron Pharma Inc.
- Current Assignee: Acceleron Pharma Inc.
- Current Assignee Address: US MA Cambridge
- Agency: Ropes & Gray LLP
- Main IPC: A61K38/17
- IPC: A61K38/17 ; C07K14/71
Abstract:
In certain aspects, the present invention provides compositions and methods for promoting bone growth and increasing bone density, as well as for the treatment of multiple myeloma.
Public/Granted literature
- US20130004489A1 ACTIVIN-ACTRIIA ANTAGONISTS AND USES FOR TREATING MULTIPLE MYELOMA Public/Granted day:2013-01-03
Information query
IPC分类:
